CoChat

Systematic Review of the Benefits of Self-Monitoring of Blood Glucose on Glycemic Control in Type 2 Diabetes Patients

Poolsup, Nalinee, Suksomboon, Naeti, Jiamsathit, Warisara · 2008 · Diabetes Technology & Therapeutics
Cited by 42

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Background: The benefit of self-monitoring of blood glucose (SMBG) in improving glycemic control in type 2 diabetes has been controversial. This systematic review evaluated the evidence of benefit of SMBG on glycemic control in non–insulin-treated type 2 diabetes. Methods: Clinical trials of SMBG were identified through electronic searches (MEDLINE, EMBASE, and The Cochrane Library) up to and including September 2007. Studies were included if they met the following inclusion criteria: (1) randomized controlled trial comparing SMBG against non-SMBG in type 2 diabetes, (2) included non–insulin-dependent patients only, and (3) hemoglobin A1c (HbA1c) reported as an outcome measure. The efficacy was estimated with the mean difference in the changes of HbA1c from baseline to final assessment between the SMBG and the non-SMBG groups. Results: SMBG was effective in reducing HbA1c in non–insulin-treated type 2 diabetes (pooled mean difference −0.24%; 95% confidence interval [CI] −0.37% to −0.12%; P = 0.0002). HbA1c decreased significantly in the SMBG subgroup where the results of SMBG were used to modify therapeutic regimens (pooled mean difference −0.27%; 95% CI −0.41% to −0.14%; P < 0.0001). In contrast, there was no significant difference in effects between the SMBG subgroup without the use of its results to modify diabetes management and the non-SMBG group (pooled mean difference −0.12%; 95% CI −0.32% to 0.08%). Conclusions: The evidence suggests the beneficial effect of SMBG in improving glycemic control in non–insulin-treated type 2 diabetes as demonstrated by the reduction of HbA1c levels. Specifically, SMBG proved to be useful only when SMBG results were used to adjust therapeutic regimens.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/dia.2008.0001

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 66

  1. 10.2337/diacare.22.2.233 · DOI · Paper page
  2. 10.1056/NEJM199309303291401 · DOI · Paper page
  3. 10.1016/S0140-6736(98)07019-6 · DOI · Paper page
  4. 10.1136/bmj.321.7258.405 · DOI · Paper page
  5. American Diabetes Association, 2006, Diabetes Care, 29, S4, 10.2337/diacare.29.s1.06.s4 · DOI · Paper page
  6. 10.1016/S1262-3636(07)70097-6 · DOI
  7. 10.1185/030079904X20286 · DOI · Paper page
  8. 10.1097/00007632-200306150-00014 · DOI · Paper page
  9. 10.1016/0197-2456(95)00134-4 · DOI · Paper page
  10. 10.1016/S0895-4356(98)00131-0 · DOI · Paper page
  11. Welschen LM, 2005, Cochrane Database Syst Rev, 2, 1
  12. Deeks JJ, 2006, Chichester: John Wiley & Sons, 120
  13. 10.1177/106002809603000305 · DOI · Paper page
  14. 10.1002/sim.4780101105 · DOI · Paper page
  15. 10.1016/0197-2456(86)90046-2 · DOI · Paper page
  16. 10.1136/bmj.327.7414.557 · DOI · Paper page
  17. 10.1136/bmj.315.7109.629 · DOI · Paper page
  18. 10.2337/diacare.12.3.179 · DOI · Paper page
  19. 10.2337/dc06-2167 · DOI
  20. Barceló A, 2001, Rev Panam Salud Publica, 10, 328
  21. 10.2337/diacare.25.2.259 · DOI · Paper page
  22. 10.2337/diacare.28.5.1101 · DOI · Paper page
  23. 10.2337/diacare.28.7.1604 · DOI · Paper page
  24. 10.1093/jpepsy/jsj116 · DOI · Paper page
  25. 10.2337/diacare.13.4.386 · DOI
  26. 10.1055/s-2005-865928 · DOI
  27. Hoffman R, 2003, Diabetes, 52, A96
  28. 10.2337/diacare.26.3.732 · DOI · Paper page
  29. 10.1089/dia.2006.0021 · DOI · Paper page
  30. 10.1067/S0002-9378(03)00497-6 · DOI
  31. 10.1001/archinte.164.13.1445 · DOI · Paper page
  32. 10.1046/j.1464-5491.2003.01070.x · DOI · Paper page
  33. 10.3349/ymj.2003.44.1.1 · DOI · Paper page
  34. 10.1157/13088946 · DOI
  35. 10.1539/joh.44.28 · DOI
  36. Tatti P, 2001, Diabetes Nutr Metab, 14, 1
  37. 10.1016/0002-9343(86)90354-2 · DOI
  38. 10.1016/j.pec.2005.11.017 · DOI · Paper page
  39. Batts-Turner ML, 2002, Diabetes, 51, A210, 10.2337/diabetes.51.1.210 · DOI · Paper page
  40. 10.1016/S0168-8227(98)00027-8 · DOI · Paper page
  41. 10.1136/bmj.306.6873.332-a · doi:10.1136/bmj.306.6873.332-a
  42. 10.1089/dia.2005.7.916 · DOI
  43. Larbig M, 2003, Diabetes Nutr Metab, 16, 257
  44. Ruggiero L, 2002, Diabetes, 51, A126
  45. 10.1016/j.pec.2005.06.013 · DOI
  46. 10.2337/diacare.8.3.284 · DOI
  47. Wen L, 2004, Am J Health Syst Pharm, 61, 2401, 10.1093/ajhp/61.22.2401 · DOI
  48. Atsumi Y, 1997, Diabetes, 46, 267A
  49. Drouin P, 2002, Diabetologia, 45, A310
  50. Lankisch M, 2006, Diabetes, 55, A450
  51. O'Kane MJ, 2006, Diabetologia, 49, 550
  52. 10.1111/j.1464-5491.2006.01973.x · DOI · Paper page
  53. 10.1093/fampra/7.4.273 · DOI · Paper page
  54. 10.2337/diacare.13.10.1044 · DOI · Paper page
  55. 10.2337/dc05-2371 · DOI · Paper page
  56. 10.1177/014572179001600408 · DOI · Paper page
  57. 10.2337/diacare.27.2.478 · DOI · Paper page
  58. Fontbonne A, 1989, Diabetes Metab, 15, 255
  59. 10.1007/BF00571954 · DOI
  60. 10.1046/j.1464-5491.2000.00390.x · DOI · Paper page
  61. 10.1001/archinte.164.6.645 · DOI · Paper page
  62. 10.2337/diacare.25.1.245 · DOI · Paper page
  63. 10.1007/BF00846550 · DOI
  64. Alto WA, 2002, J Am Board Fam Pract, 15, 1
  65. 10.1177/014572170002600610 · DOI · Paper page
  66. 10.1177/014572170403000119 · DOI · Paper page

Cited by

See all 42

Metadata

Authors
Poolsup, N., Suksomboon, N., & Jiamsathit, W.
Venue
Diabetes Technology & Therapeutics
Published
2008-06
Volume
10
Issue
s1
Pages
S-51-S-66
ISSN
  • 1520-9156 (ISSN-L)
  • 1557-8593
OpenAlex
W2039135605
Cited by
42
References
14
FWCI
0.96
Type
journal article
Language
en
Open access
closed
Licence
www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.